©The Author(s) 2025.
World J Cardiol. Nov 26, 2025; 17(11): 110178
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.110178
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.110178
Table 1 Baseline characteristics of the study population stratified by prehospital aspirin use, n (%)
| Variable | Aspirin (n = 90) | No aspirin (n = 233) | P value |
| Age (year), mean ± SD | 74.2 ± 14.3 | 66.9 ± 16.7 | < 0.001 |
| Male sex | 49 (54.4) | 113 (48.5) | 0.338 |
| BMI (kg/m²), mean ± SD | 29.7 ± 7.4 | 29.7 ± 7.2 | 0.986 |
| Hypertension | 58 (64.4) | 125 (53.6) | 0.079 |
| Coronary artery disease | 44 (48.9) | 21 (9.0) | < 0.001 |
| Chronic kidney disease | 15 (16.7) | 23 (9.9) | 0.089 |
| Active malignancy | 18 (20.0) | 59 (25.3) | 0.314 |
| Smoking history | 47 (52.2) | 109 (46.8) | 0.380 |
| Heart rate on admission (bpm) | 89.0 ± 19.3 | 94.6 ± 21.4 | 0.032 |
- Citation: Suresh MG, Mohamed S, Shanmugavel Geetha H, Sekar A, Prabhu S, Sargent J, Abraham GM, Hatwal J, Batta A, Mohan B. Prehospital aspirin use is associated with improved clinical outcomes in pulmonary embolism: A retrospective case-control study. World J Cardiol 2025; 17(11): 110178
- URL: https://www.wjgnet.com/1949-8462/full/v17/i11/110178.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i11.110178